Although two patients with WT TP53 were excluded from our study, and these patients are rare in advanced ovarian cancers, a recent study of 11 ovarian tumors with WT p53 reported a worse overall survival and PFS as compared to a mutated TP53 (38). The gene discussed is TP53; the disease is ovarian carcinoma.